YR Gaitonde Centre for AIDS Research and Education is a non-profit organisation in India working in the domain of HIV/AIDS. The organisation was founded by Dr Suniti Solomon in 1993.

During the past decade, YRG Care conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "YRG Care" #1 sponsor was "AIDS Clinical Trials Group" with 5 trials, followed by "Johns Hopkins University" with 5 trials sponsored, "AIDS Malignancy Consortium" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "CONRAD" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "YRG Care" #1 collaborator was "YR Gaitonde Centre for AIDS Research and Education" with 7 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 4 trials as a collaborator, "Elton John AIDS Foundation" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "YRG Care" are "HIV Infections" (8 trials), "HIV Infection" (3 trials), "Cervical Cancer" (1 trials), "Filarial Infection" (1 trials) and "HBV Coinfection" (1 trials). Many other conditions were trialed in "YRG Care" in a lesser frequency.

Most popular intervention types in "YRG Care" are "Drug" (8 trials), "Behavioral" (7 trials), "Other" (3 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "2N(t)RTI" (1 trials), "Abacavir" (1 trials), "Abacavir/lamivudine" (1 trials), "Abacavir/lamivudine/zidovudine" (1 trials) and "Active outreach" (1 trials). Other intervention names were less common.

The vast majority of trials in "YRG Care" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "YRG Care". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in YRG Care, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in YRG Care, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".